70% who took booster didn't get Covid in third wave, says study

The survey covered 5,971 vaccinated people, of which 24 per cent were aged below 40 and 50 per cent belonged to the 40-59 age group.

vaccine
A health worker inoculates a woman with a Covid-19 booster dose at a private hospital in New Delhi | Photo: PTI
Press Trust of India New Delhi
3 min read Last Updated : Apr 27 2022 | 12:59 AM IST

Don't want to miss the best from Business Standard?

Seventy per cent of the people who received a booster dose of the Covid vaccine did not contract the disease during the third wave, according to a new study that covered around 6,000 people in India.

The study led by Dr Rajeev Jayadevan, co-chairman of the Indian Medical Association's national task force on coronavirus, said that 45 per cent of the vaccinated people who did not take a precautionary dose reported Covid in the third wave.

The survey covered 5,971 vaccinated people, of which 24 per cent were aged below 40 and 50 per cent belonged to the 40-59 age group.

Women accounted for 45 per cent of the people surveyed, while 53 per cent were healthcare workers.

Of the 5,971 people, 2,383 took the booster dose and 30 per cent of them reported Covid during the third wave, it said.

The boosted group also had a greater proportion of healthcare workers and higher N95 use.

The researchers also concluded that a long gap after the second dose correlated with a higher chance of infection during the third wave.

Also, "giving a third dose before a six-month gap did not make a difference in the infection rate", it said.

The study also showed that the third wave affected those aged below 40 the most -- around 45 per cent of them contracted the disease.

Around 39.6 per cent in the 40-59 age cohort and around 31.8 per cent in the 60-79 age group reported Covid during the third wave. Only 21.2 per cent of the people aged above 80 were infected.

Among the 2,311 people who were infected during the third wave, 4.8 per cent were asymptomatic while 53 per cent had mild symptoms. Moderate severity was reported by 41.5 per cent, while 0.69 per cent had severe disease.

The researchers said Covaxin and Covishield recipients had the same rate of infection in the third wave.

A total of 5,157 took Covishield and 2010 (39 per cent) of them reported Covid during the third wave of the infection. Of the 523 people who took Covaxin, 210 (40 per cent) reported Covid.

The third wave of the pandemic hit India in late December last year and subsided by March.

The government authorised a third dose of the same vaccine for healthcare and frontline workers, and the people aged above 60 from January 10 to mitigate the severity of infections, hospitalisation, and death.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Apr 27 2022 | 12:59 AM IST

Next Story